Clinical Trial Update: A Study to Compare the Efficacy, Safety and Tolerability of Selomax With Its Individual Components [Phase 4]

View source ↗

Summary

A Phase 4 study compares Selomax with its individual components to evaluate differences in efficacy, safety, and tolerability in primary hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Selomax

Snippet

Sponsor: AstraZeneca | Conditions: Primary Hypertension | Phase 4 | Status: COMPLETED